• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.16% Nasdaq Up 0.25%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    124.03 Down 1.54(1.23%) Jun 1, 4:00PM EDT
    |After Hours : 123.90 Down 0.13 (0.10%) Jun 1, 4:32PM EDT
    Add to Portfolio
    Prev Close:125.57
    Open:125.70
    Bid:123.01 x 100
    Ask:127.00 x 1000
    1y Target Est:133.33
    Beta:1.28
    Earnings Date:Jul 28 - Aug 3 (Est.)
    Day's Range:121.86 - 126.92
    52wk Range:55.36 - 133.54
    Volume:1,181,358
    Avg Vol (3m):1,551,090
    Market Cap:19.89B
    P/E (ttm):N/A
    EPS (ttm):-1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BMRNDown 1.23%19.89B
    FOLDDown 0.24%1.18B
    SHPGDown 1.10%50.52B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.15
    Quarterly EPS Est (Jun-15) :-0.53
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-2.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback